Biomarker Analysis Services
From Target Discovery to Clinical Biomarker Analysis
For 29 years, SBH Sciences has supported over 100 companies in drug discovery and development through specialized biomarker services, including:
- Custom biomarker assay development and validation
- Identification and evaluation of novel therapeutic targets
- Biomarker discovery and characterization
- Assessment of pharmacodynamic and biological responses
- Preclinical and clinical sample analysis
- Multiple human and animal sample types/matrices
Trusted Experience. Proven Expertise.

Know What You Need? Order Directly
Skip the quote request and browse our available fee-for-service biomarker services, explore pricing and order directly through our marketplace partner, Cypher AI.
What SBH Can Do For You
Assay Development
We develop immunoassays by screening commercial antibody pairs across multiple dilutions to optimize linear range, or by generating antibodies internally. SBH initiated the ELISA Development Kits (EDK) sold commercially by PeproTech and has built dozens of ELISAs for cytokines, proteins, and carbohydrates, including PK assays for biologics. We also transfer existing assays to more sensitive or higher-plex platforms: Ella open cartridges, custom Luminex bead panels, and SMCxPRO.
Assay Validation
Validation is designed around the intended use of the data. Each validation covers intra- and inter-assay precision, accuracy, linearity, sensitivity, specificity and selectivity, stability, reproducibility, and linear range, documented in SOPs, per-experiment files, and a full validation report. Research-use validations confirm assay performance before preclinical samples are run. Platform selection accounts for the analyte, matrix, available sample volume, reagent availability, and any prior data on a given kit or platform.
Sample Testing
We have tested thousands of preclinical and clinical samples, with studies of several hundred to several thousand samples completed on ELISA, Ella, Luminex, and Jess. Matrices include serum, plasma, whole blood, CSF, PBMC, urine, saliva, joint fluid and tissue, from mice, rats, dogs, horses, pigs, non-human primates, and humans. Many multiplex panels require under 50 uL per sample, ELISA runs can be automated when volume allows, and results are delivered through client LIMS integration or secure data transfer.
Regulatory Readiness
Our sister company, SBH Diagnostics, is a CLIA-certified lab. Scientists are trained in GLP and GCP, and instrument competency, preventive maintenance, and service records are maintained to CLIA and GLP requirements, complete with chain of custody and regulatory documentation. SBH data has been presented to the FDA, EPA, EMA, and EFSA.
What Sets Our Biomarker Capabilities Apart
Solutions tailored to every step of research
11 In-House Biomarker Platforms
Luminex, MSD, Ella, Jess, WES, Alinity, Attune NxT, CLARIOStar,Isolight,Peggy Sue, SMCxPRO, QuantStudio 6 Pro
In Vivo Biomarkers
Biomarker analysis available for mouse, rat, dog, horse, monkey, and pig analytes
Single and Multiplex Panels
Run anywhere from 1-50 analytes in a single run with custom panel designs to fit your unique research needs
Choosing the Right Approach
Share your analytes, matrix and sample volume and we'll recommend a platform
| Application | Approach |
|
Multi-analyte pharmacodynamic profiling from limited sample volume |
Multiplex panels (Luminex or MSD) |
|
Single- or low-plex readouts with high reproducibility |
Ella automated immunoassay or ELISA |
|
PK quantification of a biologic |
Custom PK ELISA, transferable to other platforms |
|
Organ injury and safety markers |
Indication panels, such as kidney injury panels |
|
Low-abundance analytes beyond the range of standard immunoassays |
SMCxPRO single-molecule counting |
|
Quantitative protein readouts with minimal sample or limited antibody supply |
Jess, Wes, or Peggy Sue automated western |
|
Analyte or species not on the menu |
Custom assay or platform transfer |
|
Clinical sample testing |
CLIA-certified testing through SBH Diagnostics |
Multiplex Immunoassays
Multiplex up to 50 analytes in one panel
Small sample volume required (<50 uL)
Save time and money with faster experiment turnaround
Capture entire pathways for more in-depth biological insight
Broad Spectrum Panels for Research Applications
Select each tab to see the full list of analytes included in each panel
Human Biomarker Panel
| BAFF/BLyS/TNFSF13B | CXCL13/BLC/BCA-1 |
| CCL20/MIP-3 alpha | IL-6R alpha |
| CD14 | TNF RII/TNFRSF1B |
| CD25/IL-2R alpha | Gp130 |
| CD27/TNFRSF7 |
Human Cytokine Panel
| CCL2/JE/MCP-1 | FGF basic/FGF2/bFGF |
| CCL3/MIP-1 alphaG-CSF | G-CSF |
| CCL4/MIP-1 beta | GM-CSF |
| CCL5/RANTES | IFN-gamma |
| CD27/TNFRSF7 | IL-1 alpha/IL-1F1 |
| CXCL5/ENA-78 | IL-1 beta/IL-1F2 |
| IL-1ra/IL-1F3 | IL-4 |
| IL-2 | IL-5 |
| IL-8/CXCL8 | IL-6 |
| IL-10 | IL-17/IL-17A |
| TNF-alpha | Thrombopoietin/Tpo |
| VEGF |
Human MMP Panel
| EMMPRIN/CD147 | MMP-8 |
| MMP-1 | MMP-9 |
| MMP-2 | MMP-10 |
| MMP-3 | MMP-12 |
| MMP-7 | MMP-13 |
Human Growth Factor Panel
| IL-9 | EGF |
| CCL3/MIP-1 alpha | FGF basic/FGF2/bFGF |
| CCL19/MIP-3 beta | Flt-3 Ligand/FLT3L |
| CD40 Ligand/TNFSF5 | G-CSF |
| CXCL2/GRO beta/MIP-2/CINC-3 | Granzyme B |
| IFN-beta | IL-3 |
| IL-8/CXCL8 | IL-17E/IL-25 |
| IL-33 | PD-L1/B7-H |
| PDGF-AA | PDGF-AB/BB |
| TGF-alpha | TRAIL/TNFSF10 |
| VEGF |
Human TGF-beta Panel
| TGF-beta 2 | TGF-beta 3 |
Human TIMP Panel
| TIMP-1 | TIMP-2 |
| TIMP-4 |
Human Th1/Th2 Performance Panel
| IL-9 | GM-CSF |
| IFN-gamma | IL-1 beta/IL-1F2 |
| IL-2 | IL-4 |
| IL-5 | IL-6 |
| IL-10 | IL-12 p70 |
| IL-13 | Lymphotoxin-alpha/TNF-beta |
| TNF-alpha |
Human Th9/Th17/Th22 Performance Panel
| IL-9 | IL-2 |
| CCL20/MIP-3 alpha | CD40 Ligand/TNFSF5 |
| GM-CSF | IFN-gamma |
| IL-1 beta/IL-1F2 | IL-4 |
| IL-5 | IL-6 |
| IL-10 | IL-12 p70 |
| IL-17/IL-17A | IL-17E/IL-25 |
| IL-33 | TNF-alpha |
| IL-13 | IL-15 |
Biomarker Panels by Indication
Select each panel to see the analytes included
Human Tumor Biomarker Panel
| CA15-3/MUC-1 | Chromogranin A |
| CA19-9 | Glypican 1 |
| CD40 Ligand/TNFSF5 | FGF basic/FGF2/bFGF |
| CEACAM-5/CD66e | Fas/TNFRSF6/CD95 |
| CYFRA21-1 | Fas Ligand/TNFSF6 |
| Chorionic Gonadotropin beta Chain (HCG beta) | Enolase 2/Neuron-specific Enolase |
| HE4/WFDC2 | HGF |
| IL-6 | IL-8/CXCL8 |
| Kallikrein 3/PSA | Leptin/OB |
| Osteopontin/OPN | Prolactin |
| SCF/c-kit Ligand | TGF-alpha |
| Thyroglobulin | TNF-alpha |
| VEGF | alpha-Fetoprotein/AFP |
Immuno-Oncology Panel
| PD-L2/B7-DC | CTLA-4 |
| TIM-3 | CXCL5/ENA-78 |
| CCL17/TARC | HVEM/TNFRSF14 |
| CD25/IL-2R alpha | IFN-gamma |
| CD27/TNFRSF7 | LAG-3 |
| CD28 | OX40 Ligand/TNFSF4 |
| CD40/TNFRSF5 | PD-L1/B7-H1 |
Human Circulating Cancer Biomarker Panel
| Antithrombin III |
| Complement Factor H (CFH) |
| Vitamin D binding protein |
| Extracellular matrix Protein 1 (ECM1) |
Human Cancer Metastasis Panel
| DKK1 | Osteoprotegerin (OPG) |
| GDF15 | Periostin |
| Neuron-specific Enolase (NSE) | Osteonectin/SPARC |
| TWEAK | TRAP5 |
| YKL40/CHI3L1 |
Human Angiogenesis/Growth Factor Panel
| Angiopoietin-2 | EGF |
| BMP-9 | Endoglin |
| Endothelin-1 | FGF-1/FGF-acidic |
| FGF-2/FGF-basic | Follistatin (FST) |
| G-CSF | HB-EGF |
| HGF | IL-8/CXCL8 |
| Leptin | Placental Growth Factor (PGF) |
| VEGF-C | VEGF-A |
| VEGF-D |
Human Exosome Characterization Panel
| Argonaute-2 (Ago2)* | Calreticulin (CALR) |
| CD9 | CD63 |
| CD81 | Flotillin-1 (FLOT-1) |
| GAPDH | Syntenin-1 (Syn-1) |
| TSG10 |
Human Metabolic Panel
| C-Peptide | CCL2/JE/MCP-1 |
| CCL2/JE/MCP-1 | Ghrelin |
| Glucagon | IFN-gamma |
| IL-6 | Insulin |
| Leptin/OB | Pancreatic Polypeptide/PP |
| Peptide YY | TNF-alpha |
Human Obesity Panel
| Adiponectin/Acrp30 | C-Reactive Protein/CRP |
| CCL2/JE/MCP-1 | Complement Factor D/Adipsin |
| IL-6 | IL-10 |
| Leptin/OB | Resistin |
| Serpin E1/PAI-1 | TNF-alpha |
Human IGF Binding Protein Panel
| IGFBP1 | IGFBP5 |
| IGFBP2 | IGFBP6 |
| IGFBP3 | IGFBP7 |
| IGFBP4 |
Human Pituitary Panel
| ACTH | CNTF |
| FSH | GH |
| TSH | LH |
|
Agouti-Related Protein (AgRP) |
Bio-Plex Pro™ Human Inflammation Panel
| APRIL / TNFSF13 | BAFF / TNFSF13B |
| sCD30 / TNFRSF8 | Chitinase-3-like 1 |
| sCD163 | Chitinase-3-like 1 |
| gp130 / sIL-6Rβ | IFN-α2 |
| IFN-β | IFN-γ |
| IL-2 | sIL-6Rα |
| IL-8 | IL-10 |
| IL-11 | IL-12 (p40) |
| IL-12 (p70) | IL-19 |
| IL-20 | IL-22 |
| IL-26 | IL-27 (p28) |
| IL-28A / IFN-λ2 | IL-29/IFN-λ1 |
| IL-32 | IL-34 |
| IL-35 | LIGHT / TNFSF14 |
| MMP-1 | MMP-2 |
| MMP-3 | Osteocalcin |
| Osteopontin | Pentraxin-3 |
| sTNF-R1 | sTNF-R2 |
| TSLP | TWEAK / TNFSF12 |
Human Treg Cytokine Panel
| IL-2 | IL-10 |
| IL-12 (p40) | IL-12 (p70) |
| IL-19 | IL-20 |
| IL-22 | IL-26 |
| IL-27 (p28) | IL-28A / IFN-λ2 |
| IL-29 / IFN-λ1 | IL-35 |
Human Kidney Biomarker Panel
| Clusterin | CXCL10/IP-10/CRG-2 |
| Cystatin C | Lipocalin-2/NGAL |
| Osteopontin/OPN | TFF3 |
Human Kidney Injury Panel 1
| Calbindin | Collagen IV |
| GSTα | IP-10/CXCL10 |
| KIM-1 | Renin |
| TFF-3 | TIMP-1 |
Human Kidney Injury Panel 2
| α-1-Microglobulin | Albumin |
| Clusterin | Cystatin C |
| EGF | NGAL/Lipocalin-2 |
| Osteopontin (OPN) |
Human Kidney Injury Panel 4
| EGF | FABP1 |
| IP-10/CXCL10 | KIM-1 |
| Osteopontin (OPN) | PTH |
| Renin |
Human Alzheimer Panel (Amyloid Beta and Tau)
| Amyloid beta 1-40 | Amyloid beta 1-42 |
| pTau (Thr181) | Tau (total) |
Human Neurodegenerative Autoantibody IgG Panel
| α-synuclein | Aβ42 |
| AChR | AGNA (SOX1) |
| Ago2 (Su) | AMPA-R |
| Amphiphysin | ANNA2 (Ri)/NOVA1 |
| AQP4 | C1q |
| CRMP5 | CRYAB |
| DPPX | DRD2 |
| ELAVL4 (HuD) | GFAP |
| MOG | NF-L |
| NMDAR1 | NRXN3 |
| PNMA1 (Ma1) | PCA1 (Yo)/CDR2 |
| MBP | mGluR1 |
| TTau |
Human Neurological Disorders Panel
| Angiotensinogen (AGT) | Contactin-1 |
| Fetuin A | Kallikrein-6 |
| Osteopontin (OPN) | Soluble Superoxide |
| Dismutase 1 (sSOD1) | Dismutase 2 (sSOD2) |
Simple Plex Assays
Common Analytes By Indication
Neurology
Cancer
Inflammation
Cell & Gene Therapy
| IL-2 | p24 | Granzyme A, Granzyme B |
| IL-7 | IFN-gamma | |
| Il-12 | IL-1 beta | |
| IL-15 | IL-2 | |
| IL-18 | IL-10 | |
| Perforin | ||
| TNF-alpha |
| Cell Characterization | In vivo |
|---|---|
| Granzyme B | Granzyme A, Granzyme B |
| IFN-gamma | IFN-gamma |
| Il-2 | IL-6 |
| Perforin | IL-10 |
| TNF-alpha | IL-15 |
Impurities |
IP-10 |
| HEK 293 HCP 3G | TNF-alpha |
| Endonuclease | |
| CHO HCP 3G-1 | |
| GFP | |
| Protein A |
Immunoassays for Animal Models





Mouse
| Adiponectin | Cystatin C | IL-1 beta | MMP-9 | Thrombospondin-4 |
| Angiopoietin-2 | Dkk-1 | IL-2 | MMP-12 | TIM-1/KIM-1 |
| BAFF/BLyS | DPPIV/CD26 | IL-3 | Nephrin | TIMP-1 |
| CRP | EGF | IL-4 | beta-NGF | TIMP-4 |
| C1qR1 | EGF R | IL-5 | Oncostatin M | TNF-alpha |
| CCL2/MCP-1/JE | EMMPRIN | IL-6 | Osteopontin | TNF RI |
| CCL3/MIP-1 alpha | Endoglin | IL-6 R alpha | Osteoprotegerin | TNF RII |
| CCL4/MIP-1 beta | FABP4/A-FABP | IL-7 | Pancreatic Polypeptide | TRANCE/RANK L |
| CCL5/RANTES | Fas Ligand | IL-9 | PDGF-AA | TWEAK |
| CCL7/MARC | FGF basic | IL-10 | PDGF-AB | uPAR |
| CCL8/MCP-2 | FGF-21 | IL-12 p70 | PDGF-BB | VEGF |
| CCL11/Eotaxin | G-CSF | IL-13 | Periostin/OSF-2 | VEGF R2 |
| CCL12/MCP-5 | Galectin-3 | IL-16 | PlGF-2 | |
| CCL19/MIP-3 beta | GDF-15 | IL-17A | Podocalyxin | |
| CCL20/MIP-3 alpha | Glucagon | IL-17E/IL-25 | Prolactin | |
| CCL21/6Ckine | GM-CSF | IL-23 p19 | PCSK9 | |
| CCL22/MDC | Granzyme B | IL-27 | RAGE | |
| Chitinase 3-like 1/ YKL-40 | Haptoglobin | IL-33 | Renin | |
| Factor D/Adipsin | HGF | LDL R | Resistin | |
| CXCL1/KC | ICAM-1 | Lipocalin-2/NGAL | S100A8 | |
| CXCL2/MIP-2 | IFN-gamma | LIX | S100A9 | |
| CXCL10/IP-10 | IGF-I | M-CSF | P-Selectin | |
| CXCL12/SDF-1 alpha | IGFBP-1 | MMP-2 | Serpin E1/PAI-1 | |
| CXCL13/BLC/BCA-1 | IGFBP-3 | MMP-3 | SOST | |
| CXCL16 | IL-1 alpha | MMP-8 | SP-D |
Rat
| EGF | Eotaxin/CCL11 | Fractalkine | G-CSF | GM-GSF |
| GRO/KC | IFN-ϒ | IL-1α | IL-1β | IL-2 |
| IL-4 | IL-5 | IL-6 | IL-10 | IL-12 (p70) |
| IL-13 | IL17A | IL-18 | IP-10 | Leptin |
| LIX | MCP-1 | MIP-1α | MIP-2 | RANTES |
| TNF-α | VEGF |
Canine
| GM-CSF | IL-2 | IL-7 | IL-6 | IL-8 |
| IFN-ϒ | IL-10 | IL-15 | IL-18 | IP-10 |
| KC-like | MCP-1 | TNF-α |
Pig
| GM-CSF | IL-2 | IL-4 | IL-6 | IL-8 |
| IFN-ϒ | IL-10 | IL-1α | IL-18 | IL-1rα |
| IL-1β | IL-12 | TNF-α |
Equine
| G-CSF | IL-2 | IL-4 | IL-6 | IL-8 |
| IFN-ϒ | IL-10 | IL-1α | IL-18 | IL-5 |
| IL-1β | IL-12 (p70) | TNF-α | IL-13 | IL-17A |
| Eotaxin/CCL11 | FGF-2 | Fractalkine/CX3CL1 | GRO/KC | MCP-1 |
| RANTES |
Answers from a Research Partner You can Trust Common Questions
Which animal species do you work with?
We test samples from mice, rats, dogs, horses, pigs, and non-human primates.
What sample types can you test?
Serum, plasma, whole blood, CSF, urine, saliva, cell culture supernatants, and tissue.
Can you test clinical trial samples?
Yes. We have tested thousands of samples, including clinical trial samples, and can handle chain of custody, storage, and documentation. We have validated several biomarkers for use in Phase I - III clinical trials.
How quickly can you develop a custom assay?
Our dedicated and experienced team can deliver rapid custom assay development in as little as 2 weeks.
